The International Medical Cannabis Conference (IMCC) in Bern represents the pinnacle of scientific and clinical discourse on cannabis therapeutics. Held in neutral Switzerland, this prestigious two-day conference brings together the world’s leading researchers, physicians, pharmacologists, and policymakers to advance the understanding and application of medical cannabis. Unlike industry trade shows focused on business, IMCC prioritizes science. Presentations feature peer-reviewed research on cannabinoid pharmacology, clinical trial results, dosing protocols, drug interactions, and emerging therapeutic applications. Attendees include oncologists, neurologists, pain specialists, psychiatrists, and other clinicians seeking evidence-based guidance for treating patients with cannabis-based medicines. The conference addresses crucial topics including standardization of medical cannabis products, quality control in production, patient access challenges, and the evolving regulatory landscape across Europe and beyond. Panel discussions encourage dialogue between researchers, clinicians, and regulators, fostering the collaboration needed to advance the field. Switzerland’s progressive approach to medical cannabis research makes Bern an ideal host city. Attendees gain insights from Swiss clinical programs while connecting with colleagues from established medical cannabis markets worldwide. For healthcare professionals serious about cannabinoid medicine, IMCC is the most important scientific gathering of the year.